Gestational Response, Outcomes, and Weight After GLP-1 Use

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-45
SponsorUniversity of Kansas Medical Center

About this trial

The goal of this observational study is to learn if using GLP-1RA medications for weight loss before pregnancy influences gestational weight gain and pregnancy outcomes. The main aims of the study are to:

* Compare gestational weight gain between women with preconception GLP-1RA exposure and those without exposure. * Compare obstetrical outcomes between women with preconception GLP-1RA exposure and those without exposure.

Researchers will compare pregnant women with a history of GLP-1RA use to pregnant women who have not used a GLP-1RA to compare differences.

Participants will be asked to complete questionnaires at multiple timepoints during and after pregnancy that ask questions about medication history, thoughts and feelings around food, etc.

Eligibility criteria

Qualifiers

Adult women

Less than or equal to 20 weeks gestation at first visit

English speaking

Disqualifiers

<18 years at time of initial visit

Type 2 diabetes

History of bariatric surgery

Multiple gestation

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

400 Participants
are grouped into 2 trial groups